81_FR_42845 81 FR 42719 - National Cancer Institute; Notice of Closed Meetings

81 FR 42719 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 126 (June 30, 2016)

Page Range42719-42720
FR Document2016-15447

Federal Register, Volume 81 Issue 126 (Thursday, June 30, 2016)
[Federal Register Volume 81, Number 126 (Thursday, June 30, 2016)]
[Notices]
[Pages 42719-42720]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-15447]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Member Conflict SEP.
    Date: July 6, 2016.

[[Page 42720]]

    Time: 10:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W602, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Delia Tang, MD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W602, Rockville, MD 20850 240-276-7684, tangd@mail.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 24, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-15447 Filed 6-29-16; 8:45 am]
BILLING CODE 4140-01-P



                                                                                Federal Register / Vol. 81, No. 126 / Thursday, June 30, 2016 / Notices                                                  42719

                                                     Background Information on                            and Transplantation Research; 93.856,                  simultaneously detected by each
                                                  NICEATM: NICEATM conducts data                          Microbiology and Infectious Diseases                   respective objective lens along a
                                                  analyses, workshops, independent                        Research, National Institutes of Health, HHS)          respective longitudinal axis. Including
                                                  validation studies, and other activities                  Dated: June 24, 2016.                                multiple lenses will improve the
                                                  to assess new, revised, and alternative                 Natasha M. Copeland,                                   penetration depth and at the same time
                                                  test methods and strategies. NICEATM                    Program Analyst, Office of Federal Advisory            decrease the loss of detail because of
                                                  also provides support for the                           Committee Policy.                                      scattering. The system also can
                                                  Interagency Coordinating Committee on                   [FR Doc. 2016–15443 Filed 6–29–16; 8:45 am]            overcome losses in spatial resolution
                                                  the Validation of Alternative Methods                   BILLING CODE 4140–01–P
                                                                                                                                                                 because of the scattering of the
                                                  (ICCVAM). The ICCVAM Authorization                                                                             excitation and emission light.
                                                  Act of 2000 (42 U.S.C. 285l–3) provides                                                                        Potential Commercial Applications:
                                                  authority for ICCVAM and NICEATM in                     DEPARTMENT OF HEALTH AND                                 —High resolution multi-photon
                                                  the development of alternative test                     HUMAN SERVICES                                              microscopy
                                                  methods. Information about NICEATM                                                                               —Deep tissue visualization
                                                  and ICCVAM is found at http://                          National Institutes of Health                          —Competitive Advantages:
                                                  ntp.niehs.nih.gov/go/niceatm and                                                                                 —Improved signal-to-noise ratio
                                                  http://ntp.niehs.nih.gov/go/iccvam.                     Government-Owned Inventions;                             —improved spatial resolution
                                                                                                          Availability for Licensing                             —Development Stage:
                                                    Dated: June 24, 2016.
                                                  John R. Bucher,                                         AGENCY:    National Institutes of Health,                • Prototype
                                                  Associate Director, National Toxicology                 HHS.                                                     Inventors: Yicong Wu (NIBIB), Hari
                                                  Program.                                                ACTION:   Notice.                                      Shroff (NIBIB), Jianyong Tang (NIAID),
                                                  [FR Doc. 2016–15444 Filed 6–29–16; 8:45 am]                                                                    Ronald Germain (NIAID).
                                                                                                          SUMMARY:   The inventions listed below                   Intellectual Property: HHS Reference
                                                  BILLING CODE 4140–01–P
                                                                                                          are owned by an agency of the U.S.                     No. E–229–2015/0; U.S. Provisional
                                                                                                          Government and are available for                       Patent Application 62/210,153 filed
                                                  DEPARTMENT OF HEALTH AND                                licensing in the U.S. in accordance with               August 26, 2015.
                                                  HUMAN SERVICES                                          35 U.S.C. 209 and 37 CFR part 404 to                     Licensing Contact: Michael
                                                                                                          achieve expeditious commercialization                  Shmilovich, Esq, CLP; 301–435–5019;
                                                  National Institutes of Health                           of results of federally-funded research                shmilovm@mail.nih.gov.
                                                                                                          and development.
                                                  National Institute of Allergy and                                                                                Dated: June 24, 2016.
                                                                                                          FOR FURTHER INFORMATION CONTACT:
                                                  Infectious Diseases; Notice of Closed                                                                          Michael Shmilovich,
                                                                                                          Licensing information may be obtained
                                                  Meeting                                                 by emailing the indicated licensing                    Senior Licensing and Patenting Manager,
                                                                                                                                                                 National Heart, Lung, and Blood Institute,
                                                    Pursuant to section 10(d) of the                      contact at the National Heart, Lung, and
                                                                                                                                                                 Office of Technology Transfer and
                                                  Federal Advisory Committee Act, as                      Blood, Office of Technology Transfer                   Development.
                                                  amended (5 U.S.C. App.), notice is                      and Development Office of Technology
                                                                                                                                                                 [FR Doc. 2016–15441 Filed 6–29–16; 8:45 am]
                                                  hereby given of the following meeting.                  Transfer, 31 Center Drive Room 4A29,
                                                                                                                                                                 BILLING CODE 4140–01–P
                                                    The meeting will be closed to the                     MSC2479, Bethesda, MD 20892–2479;
                                                  public in accordance with the                           telephone: 301–402–5579. A signed
                                                  provisions set forth in sections                        Confidential Disclosure Agreement may                  DEPARTMENT OF HEALTH AND
                                                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              be required to receive any unpublished                 HUMAN SERVICES
                                                  as amended. The grant applications and                  information.
                                                  the discussions could disclose                          SUPPLEMENTARY INFORMATION:                             National Institutes of Health
                                                  confidential trade secrets or commercial                Technology description follows.
                                                  property such as patentable material,                                                                          National Cancer Institute; Notice of
                                                                                                          Multi-Photon Microscopy System                         Closed Meetings
                                                  and personal information concerning                     Configured for Multiview Non-Linear
                                                  individuals associated with the grant                   Optical Imaging                                          Pursuant to section 10(d) of the
                                                  applications, the disclosure of which                                                                          Federal Advisory Committee Act, as
                                                  would constitute a clearly unwarranted                    This invention is a microscopy device
                                                                                                          and system for multi-photon                            amended (5 U.S.C. App.), notice is
                                                  invasion of personal privacy.                                                                                  hereby given of the following meeting.
                                                                                                          microscopy utilizing multi-view
                                                    Name of Committee: National Institute of              nonlinear optical imaging. Nonlinear                     The meeting will be closed to the
                                                  Allergy and Infectious Diseases Special                                                                        public in accordance with the
                                                  Emphasis Panel.
                                                                                                          optical imaging remains the premier
                                                                                                          technique for deep-tissue imaging in                   provisions set forth in sections
                                                    Date: July 27, 2016.                                                                                         552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                    Time: 2:00 p.m. to 5:00 p.m.                          which typically a multi photon
                                                                                                          arrangement may be used to illuminate                  as amended. The grant applications and
                                                    Agenda: To review and evaluate grant
                                                  applications.                                           and excite a sample. However, the                      the discussions could disclose
                                                    Place: National Institutes of Health, 5601            penetration depth, signal-to-noise ratio,              confidential trade secrets or commercial
                                                  Fishers Lane, Rockville, MD 20892,                      and resolution of this technique is                    property such as patentable material,
                                                  (Telephone Conference Call).                            ultimately limited by scattering. The                  and personal information concerning
                                                    Contact Person: James T. Snyder, Ph.D.,               present system addresses these issues by               individuals associated with the grant
mstockstill on DSK3G9T082PROD with NOTICES




                                                  Scientific Review Officer, Scientific Review                                                                   applications, the disclosure of which
                                                  Program, Division of Extramural Activities/
                                                                                                          sequential excitation of a sample
                                                                                                          through three or more objective lenses                 would constitute a clearly unwarranted
                                                  Room 3G31B, National Institutes of Health,                                                                     invasion of personal privacy.
                                                  NIAID, 5601 Fishers Lane MSC 9823,                      oriented at different axes intersecting
                                                  Bethesda, MD 20892–9823, (240) 669–5060,                the sample. Each objective lens is                       Name of Committee: National Cancer
                                                  james.snyder@nih.gov.                                   capable of focused sequential excitation               Institute Special Emphasis Panel; Member
                                                  (Catalogue of Federal Domestic Assistance               that elicits fluorescence emissions from               Conflict SEP.
                                                  Program Nos. 93.855, Allergy, Immunology,               the excited sample, which is then                        Date: July 6, 2016.



                                             VerDate Sep<11>2014   20:01 Jun 29, 2016   Jkt 238001   PO 00000   Frm 00091   Fmt 4703   Sfmt 4703   E:\FR\FM\30JNN1.SGM   30JNN1


                                                  42720                         Federal Register / Vol. 81, No. 126 / Thursday, June 30, 2016 / Notices

                                                    Time: 10:30 a.m. to 3:00 p.m.                         published in the Federal Register                      HHS-Certified Laboratories
                                                    Agenda: To review and evaluate grant                  during the first week of each month. If
                                                  applications.                                                                                                  ACM Medical Laboratory, Inc., 160
                                                                                                          any laboratory or IITF certification is                  Elmgrove Park, Rochester, NY 14624,
                                                    Place: National Cancer Institute Shady
                                                                                                          suspended or revoked, the laboratory or                  585–429–2264
                                                  Grove, 9609 Medical Center Drive, Room
                                                  7W602, Rockville, MD 20850, (Telephone                  IITF will be omitted from subsequent                   Aegis Analytical Laboratories, Inc., 345
                                                  Conference Call).                                       lists until such time as it is restored to               Hill Ave., Nashville, TN 37210, 615–
                                                    Contact Person: Delia Tang, MD, Scientific            full certification under the Mandatory                   255–2400, (Formerly: Aegis Sciences
                                                  Review Officer, Research Programs Review                Guidelines.                                              Corporation, Aegis Analytical
                                                  Branch, Division of Extramural Activities,                 If any laboratory or IITF has                         Laboratories, Inc., Aegis Analytical
                                                  National Cancer Institute, NIH, 9609 Medical
                                                  Center Drive, Room 7W602, Rockville, MD
                                                                                                          withdrawn from the HHS National                          Laboratories)
                                                  20850 240–276–7684, tangd@mail.nih.gov.                 Laboratory Certification Program (NLCP)                Alere Toxicology Services, 1111 Newton
                                                                                                          during the past month, it will be listed                 St., Gretna, LA 70053, 504–361–8989/
                                                    This notice is being published less than 15
                                                  days prior to the meeting due to the timing             at the end and will be omitted from the                  800–433–3823, (Formerly: Kroll
                                                  limitations imposed by the review and                   monthly listing thereafter.                              Laboratory Specialists, Inc.,
                                                  funding cycle.                                             This notice is also available on the                  Laboratory Specialists, Inc.)
                                                  (Catalogue of Federal Domestic Assistance               Internet at http://www.samhsa.gov/                     Alere Toxicology Services, 450
                                                  Program Nos. 93.392, Cancer Construction;               workplace.                                               Southlake Blvd., Richmond, VA
                                                  93.393, Cancer Cause and Prevention                                                                              23236, 804–378–9130, (Formerly:
                                                  Research; 93.394, Cancer Detection and                  FOR FURTHER INFORMATION CONTACT:                         Kroll Laboratory Specialists, Inc.,
                                                  Diagnosis Research; 93.395, Cancer                      Giselle Hersh, Division of Workplace                     Scientific Testing Laboratories, Inc.;
                                                  Treatment Research; 93.396, Cancer Biology              Programs, SAMHSA/CSAP, 5600                              Kroll Scientific Testing Laboratories,
                                                  Research; 93.397, Cancer Centers Support;                                                                        Inc.)
                                                                                                          Fishers Lane, Room 16N03A, Rockville,
                                                  93.398, Cancer Research Manpower; 93.399,                                                                      Baptist Medical Center—Toxicology
                                                  Cancer Control, National Institutes of Health,          Maryland 20857; 240–276–2600 (voice).
                                                  HHS)
                                                                                                                                                                   Laboratory, 11401 I–30, Little Rock,
                                                                                                          SUPPLEMENTARY INFORMATION:       The                     AR 72209–7056, 501–202–2783,
                                                    Dated: June 24, 2016.                                 Mandatory Guidelines were initially                      (Formerly: Forensic Toxicology
                                                  Melanie J. Gray,                                        developed in accordance with Executive                   Laboratory Baptist Medical Center)
                                                  Program Analyst, Office of Federal Advisory             Order 12564 and section 503 of Public                  Clinical Reference Lab, 8433 Quivira
                                                  Committee Policy.                                       Law 100–71. The ‘‘Mandatory                              Road, Lenexa, KS 66215–2802, 800–
                                                  [FR Doc. 2016–15447 Filed 6–29–16; 8:45 am]             Guidelines for Federal Workplace Drug                    445–6917
                                                  BILLING CODE 4140–01–P
                                                                                                          Testing Programs,’’ as amended in the                  DrugScan, Inc., 200 Precision Road,
                                                                                                          revisions listed above, requires strict                  Suite 200, Horsham, PA 19044, 800–
                                                                                                          standards that laboratories and IITFs                    235–4890
                                                  DEPARTMENT OF HEALTH AND                                must meet in order to conduct drug and                 Dynacare*, 245 Pall Mall Street,
                                                  HUMAN SERVICES                                          specimen validity tests on urine                         London, ONT, Canada N6A 1P4, 519–
                                                                                                          specimens for federal agencies.                          679–1630, (Formerly: Gamma-
                                                  Substance Abuse and Mental Health                          To become certified, an applicant                     Dynacare Medical Laboratories)
                                                  Services Administration                                 laboratory or IITF must undergo three                  ElSohly Laboratories, Inc., 5 Industrial
                                                                                                          rounds of performance testing plus an                    Park Drive, Oxford, MS 38655, 662–
                                                  Current List of HHS-Certified
                                                                                                          on-site inspection. To maintain that                     236–2609
                                                  Laboratories and Instrumented Initial
                                                                                                          certification, a laboratory or IITF must               Fortes Laboratories, Inc., 25749 SW
                                                  Testing Facilities Which Meet Minimum
                                                                                                          participate in a quarterly performance                   Canyon Creek Road, Suite 600,
                                                  Standards To Engage in Urine Drug
                                                                                                          testing program plus undergo periodic,                   Wilsonville, OR 97070, 503–486–1023
                                                  Testing for Federal Agencies
                                                                                                          on-site inspections.                                   Laboratory Corporation of America
                                                  AGENCY: Substance Abuse and Mental                         Laboratories and IITFs in the                         Holdings, 7207 N. Gessner Road,
                                                  Health Services Administration, HHS                     applicant stage of certification are not to              Houston, TX 77040, 713–856–8288/
                                                  ACTION: Notice                                          be considered as meeting the minimum                     800–800–2387
                                                                                                          requirements described in the HHS                      Laboratory Corporation of America
                                                  SUMMARY:    The Department of Health and                Mandatory Guidelines. A HHS-certified                    Holdings, 69 First Ave., Raritan, NJ
                                                  Human Services (HHS) notifies federal                   laboratory or IITF must have its letter of               08869, 908–526–2400/800–437–4986,
                                                  agencies of the laboratories and                        certification from HHS/SAMHSA                            (Formerly: Roche Biomedical
                                                  Instrumented Initial Testing Facilities                 (formerly: HHS/NIDA), which attests                      Laboratories, Inc.)
                                                  (IITF) currently certified to meet the                  that it has met minimum standards.                     Laboratory Corporation of America
                                                  standards of the Mandatory Guidelines                                                                            Holdings, 1904 Alexander Drive,
                                                  for Federal Workplace Drug Testing                         In accordance with the Mandatory                      Research Triangle Park, NC 27709,
                                                  Programs (Mandatory Guidelines). The                    Guidelines dated November 25, 2008                       919–572–6900/800–833–3984,
                                                  Mandatory Guidelines were first                         (73 FR 71858), the following HHS-                        (Formerly: LabCorp Occupational
                                                  published in the Federal Register on                    certified laboratories and IITFs meet the                Testing Services, Inc., CompuChem
                                                  April 11, 1988 (53 FR 11970), and                       minimum standards to conduct drug                        Laboratories, Inc.; CompuChem
                                                  subsequently revised in the Federal                     and specimen validity tests on urine                     Laboratories, Inc., A Subsidiary of
                                                  Register on June 9, 1994 (59 FR 29908);                 specimens:                                               Roche Biomedical Laboratory; Roche
mstockstill on DSK3G9T082PROD with NOTICES




                                                  September 30, 1997 (62 FR 51118);                       HHS-Certified Instrumented Initial                       CompuChem Laboratories, Inc., A
                                                  April 13, 2004 (69 FR 19644); November                  Testing Facilities                                       Member of the Roche Group)
                                                  25, 2008 (73 FR 71858); December 10,                                                                           Laboratory Corporation of America
                                                  2008 (73 FR 75122); and on April 30,                    Dynacare, 6628 50th Street NW.,                          Holdings, 1120 Main Street,
                                                  2010 (75 FR 22809).                                       Edmonton, AB Canada T6B 2N7, 780–                      Southaven, MS 38671, 866–827–8042/
                                                     A notice listing all currently HHS-                    784–1190, (Formerly: Gamma-                            800–233–6339, (Formerly: LabCorp
                                                  certified laboratories and IITFs is                       Dynacare Medical Laboratories)                         Occupational Testing Services, Inc.;


                                             VerDate Sep<11>2014   20:01 Jun 29, 2016   Jkt 238001   PO 00000   Frm 00092   Fmt 4703   Sfmt 4703   E:\FR\FM\30JNN1.SGM   30JNN1



Document Created: 2018-02-08 07:45:34
Document Modified: 2018-02-08 07:45:34
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 6, 2016.
FR Citation81 FR 42719 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR